Genome-Wide Integrated Analyses of Androgen Receptor Signaling in Prostate Cancer Based on High-Throughput Technology

E-ISSN： 1873-5592|14|4|472-480

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.4, 2013-04, pp. : 472-480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The androgen receptor as a therapeutic target in prostate cancer

By Visakorpi T.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Androgen Receptor Antagonists in the Treatment of Prostate Cancer

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 1, Iss. 1, 2014-06 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Androgen Receptor Antagonists in Prostate Cancer

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 8, 2014-06 ,pp. : 655-663

Bentham Science Publishers

Access to resources Recommend Favorite

Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer

Current Medicinal Chemistry, Vol. 20, Iss. 1, 2013-01 ,pp. : 144-157

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 420-440

Bentham Science Publishers

Access to resources Recommend Favorite